Healthcare providers should reassess the benefit-risk profile periodically and consider discontinuation if patients do not achieve clinically meaningful weight loss or experience intolerable adverse effects
That works until complexity grows: missed doses, inconsistent protein intake, and untracked nausea cause wasted refills and slower progress, translating directly into dollars lost and time spent
As part of the vanguard in these cases, RTRLAW represents clients in these lawsuits, as well as other consumer product lawsuits, ensuring their cases are heard and justice is served
Defying fears of losing significant market share to generics, innovators Novo Nordisk and Eli Lilly, along with their domestic partners Cipla, Emcure, and Abbott, have continued to show steady month-on-month growth, indicating a loyal prescriber base and patient onboarding